Does inhibition of ADAMTS4 improve cardiac function and reduce collagen accumulation in rats with cardiac pressure overload?
Targeting ADAMTS4 may serve as a novel strategy for treating heart failure with fibrosis and diastolic dysfunction by improving cardiac function and reducing collagen accumulation.
Inhibition of ADAMTS4 improves cardiac function and reduces collagen accumulation in rats with cardiac pressure overload, possibly through a not previously known cleavage of molecules that control TGF-β availability. Targeting ADAMTS4 may serve as a novel strategy in heart failure treatment, in particular, in heart failure with fibrosis and diastolic dysfunction.
Vistnes et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: